Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery

FEBS Lett. 2002 Nov 6;531(2):122-6. doi: 10.1016/s0014-5793(02)03388-4.

Abstract

Metalloproteinases (MMP)-2 and MMP-9 play a role in smooth muscle cell (SMC) migration from the media to the intima following arterial injury. Intravenous administration of adenovirus encoding tissue inhibitor of metalloproteinase-1 (TIMP-1) into balloon-injured rat arteries (3 x 10(11) viral particles/rat; n=7) resulted in a transient expression of TIMP-1 and a significant inhibition of neointima thickening within 16 days ( approximately 40% vs. control; P=0.012). Three days after injury, the number of intimal SMCs was decreased by approximately 98% in TIMP-1-treated rats. However, no alteration was seen in intimal SMC proliferation after 13 days of injury. Therefore, our results show that systemic gene transfer of TIMP-1 is a promising approach in early restenosis treatment.

MeSH terms

  • Adenoviridae / genetics
  • Angioplasty, Balloon / adverse effects*
  • Animals
  • Carotid Arteries / pathology*
  • Carotid Stenosis / etiology
  • Carotid Stenosis / pathology
  • Carotid Stenosis / therapy*
  • Cell Movement
  • Genetic Therapy*
  • Genetic Vectors / administration & dosage
  • Humans
  • Hyperplasia
  • Injections, Intravenous
  • Kinetics
  • Male
  • Matrix Metalloproteinases / metabolism
  • Muscle, Smooth, Vascular / physiopathology
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Inhibitor of Metalloproteinase-1 / blood
  • Tissue Inhibitor of Metalloproteinase-1 / genetics*

Substances

  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinases